Tuesday, December 6, 2016

BRIEF-Kiadis Pharma presents positive follow-up data of ATIR101 Phase II trial

* Presents positive 1-year follow-up data of its pivotal Phase II Trial with ATIR101

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)